Jitesh Rana

Statistics

Publications

Citations

600

H-Index

Active since

2013

Affiliations

Biogen (United States)(Current)

Baylor University

Ruhr University Bochum

St. Josef-Hospital

Cleveland Clinic

Jitesh Rana is an author at Biogen (United States) specializing in multiple sclerosis, multiple sclerosis therapy, and relapsing-remitting multiple sclerosis treatment.

Publications per year

2013–2017

Publications

Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial

Ralf Gold, Gavin Giovannoni, Krzysztof Selmaj et al. · The Lancet · 2013 · 287 citations

Life Sciences, Neurology, Pharmacotherapy +9

Randomized phase I trials of the safety/tolerability of anti-LINGO-1 monoclonal antibody BIIB033

Jonathan Q. Tran, Jitesh Rana, Frederik Barkhof et al. · Neurology Neuroimmunology & Neuroinflammation · 2014 · 124 citations · Full text

Pharmacy, Neurology, Pharmacology +14

Characterizing absolute lymphocyte count profiles in dimethyl fumarate–treated patients with MS

Robert J. Fox, Andrew Chan, Ralf Gold et al. · Neurology Clinical Practice · 2016 · 104 citations · Full text

Life Sciences, Immunology, Pharmacology +14

Consensus Management of Gastrointestinal Events Associated with Delayed-Release Dimethyl Fumarate: A Delphi Study

J. Theodore Phillips, April Erwin, Stephanie Agrella et al. · Neurology and Therapy · 2015 · 38 citations · Full text

Pharmacy, Pharmacotherapy, Clinical Epidemiology +6

First-In-Human, Double-Blind, Placebo-Controlled, Randomized, Dose-Escalation Study of BG00010, a Glial Cell Line-Derived Neurotrophic Factor Family Member, in Subjects with Unilateral Sciatica

Paul Rolan, Gilmore O’Neill, Eve Versage et al. · PLoS ONE · 2015 · 25 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13

1–5 of 6